Valo.Ns

VALO.NS has negative liquidity metrics, with no balance-sheet inputs available to assess its short-term financial position. The company reported a net loss of INR 5.09 million for the period, with operating income also negative at INR 29.23 million. Gross profit was negative at INR 1.17 million, indicating significant cost pressures relative to revenue.

The company's profitability metrics are sharply below industry norms, with negative operating and net margins. While specialty chemicals firms typically have high gross margins, VALO.NS reported a negative gross margin of -0.62% (calculated as gross profit/revenue). This performance is inconsistent with the industry's median gross margin of 35-45% for comparable firms.

VALO.NS operates as a single-segment business with no geographic diversification disclosed in the available data. The company's revenue concentration in a single business line increases operational risk, particularly in a capital-intensive industry like specialty chemicals.

Revenue for the period was INR 188.84 million, but no growth trajectory can be determined due to limited historical data. The company has not disclosed forward-looking guidance or capital allocation plans in the available filings.

The risk assessment indicates low dilution potential, with basic and diluted shares outstanding equal at 54.31 million shares. However, liquidity risk could not be assessed due to missing balance-sheet data and no going-concern disclosures in source documents.

Recent filings show no material events impacting operations or capital structure. The company has not disclosed any significant regulatory changes, product launches, or strategic partnerships in the available documents.